In conclusion, sponsors should carefully consider the advantages of retaining ownership of their TMFs rather than leaving them solely with CROs. By having a TMF system under their control, sponsors can benefit from a single source of documentation, simplified management when outsourcing to multiple CROs, enhanced oversight and quality control, consistency for internal team members, and the elimination of end-of-study transfers. Furthermore, by exploring the potential risk associated with leaving the TMF with the CRO, such as poor management, missing documentation, and issues with handoffs, sponsors can appreciate the importance of taking proactive measures to ensure the integrity, accessibility, and compliance of their TMF.
Ultimately, by retaining control over their TMF, sponsors empower themselves to optimize collaboration with CROs, confidently engage with regulatory authorities, and establish a robust foundation for efficient and compliant TMF management throughout the clinical trial lifecycle.
Ready to start implementing your own eTMF System? Reach out to us!